Bank of Montreal’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Bank of Montreal’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,244	Closed	-$39	–	4439
2022 Q3	$39	Buy	+16,244	New	+$42.5K	﹤0.01%	3680
2022 Q1	–	Sell	-259,806	Closed	-$2.58M	–	4346
2021 Q4	$2.58M	Buy	259,806 +25,000	+11%	+$249K	﹤0.01%	1473
2021 Q3	$2.33M	Sell	234,806 -114,000	-33%	-$1.12M	﹤0.01%	1993
2021 Q2	$3.42M	Buy	+348,806	New	+$3.4M	﹤0.01%	1787

Other funds holding GRNA

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CGC

Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal's GRNA Position: Q4 2022 in Review

Bank of Montreal sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q4 2022, closing a stake of 16,244 shares — an estimated $39 sold.

Bank of Montreal first reported a position in GRNA in Q2 2021 and held it in 4 quarters. The position peaked at $3.42M in Q2 2021. 60 funds tracked by Wall St. Rank hold GRNA as of Q4 2022.

Bank of Montreal reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q4 2022 after selling out during the quarter.
Bank of Montreal sold 16,244 GreenLight Biosciences Holdings, PBC Common Stock shares in Q4 2022, an estimated $39.
Bank of Montreal first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2021 and held it in 4 quarters.
Bank of Montreal's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $3.42M in Q2 2021.
60 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q4 2022.

Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.